$CTGO
Contango ORE, Inc. Stock $ctgo

$ctgo Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000143774922021579 Filed on August 31, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.424M	$2.341M	$10.34M
YoY Change	23.03%	12.12%	-0.25%
% of Gross Profit
Research & Development	$4.544M	$4.522M	$9.139M
YoY Change	314.53%	4039.57%	2947.43%
% of Gross Profit
Depreciation & Amortization	$34.21K	$31.79K	$55.74K
YoY Change	615.47%
% of Gross Profit
Operating Expenses	$6.663M	$6.895M	$19.53M
YoY Change	116.97%	213.78%	83.18%
Operating Profit
YoY Change
Interest Expense	$449.5K	-$326.3K	$330.0K
YoY Change	694.06%	-746.17%	-99.08%
% of Operating Profit
Other Income/Expense, Net	-$86.97K	$41.45K	-$3.993M
YoY Change	-94.21%		-111.14%
Pretax Income	-$7.092M	-$7.232M	-$23.63M
YoY Change	55.11%	236.82%	-193.86%
Income Tax	$0.00	$0.00	-$119.7K
% Of Pretax Income
Net Earnings	-$7.092M	-$7.232M	-$23.51M
YoY Change	55.11%	291.04%	-198.48%
Net Earnings / Revenue
Basic Earnings Per Share	-$1.05		-$3.49
Diluted Earnings Per Share	-$1.05	-$1.069M	-$3.49
COMMON SHARES
Basic Shares Outstanding	6.776M	6.770M	6.734M
Diluted Shares Outstanding	6.771M		6.734M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.81M	$23.10M	$23.10M
YoY Change	-33.44%	-34.43%	-34.43%
Cash & Equivalents	$17.81M	$23.10M
Short-Term Investments
Other Short-Term Assets	$671.0K	$684.4K	$684.4K
YoY Change	-15.37%	32.72%	32.72%
Inventory
Prepaid Expenses	$440.0K	$453.4K
Receivables
Other Receivables
Total Short-Term Assets	$18.48M	$23.78M	$23.78M
YoY Change	-33.59%	-33.83%	-33.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.48M	$13.51M	$13.51M
YoY Change	-1.12%	36894.69%	36895.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00	$0.00
YoY Change
Other Assets	$13.48M	$13.51M
YoY Change	-1.12%	36894.69%
Total Long-Term Assets	$13.48M	$13.51M	$13.51M
YoY Change	-1.12%	36894.69%	36895.73%
TOTAL ASSETS
Total Short-Term Assets	$18.48M	$23.78M	$23.78M
Total Long-Term Assets	$13.48M	$13.51M	$13.51M
Total Assets	$31.96M	$37.29M	$37.29M
YoY Change	-22.91%	3.68%	3.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.210M	$633.9K	$633.9K
YoY Change	121.62%	2313.03%	2312.87%
Accrued Expenses	$1.104M	$871.0K	$871.0K
YoY Change	148.24%	344.75%	344.74%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.315M	$1.505M	$1.505M
YoY Change	-68.03%	577.53%	577.52%
LONG-TERM LIABILITIES
Long-Term Debt	$19.29M	$19.24M	$19.24M
YoY Change
Other Long-Term Liabilities	$3.278M	$3.275M	$3.275M
YoY Change	0.37%	172.93%	172.93%
Total Long-Term Liabilities	$22.56M	$22.52M	$22.52M
YoY Change	590.9%	1776.26%	1776.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.315M	$1.505M	$1.505M
Total Long-Term Liabilities	$22.56M	$22.52M	$22.52M
Total Liabilities	$24.88M	$24.02M	$24.02M
YoY Change	136.79%	1589.04%	1589.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$65.63M	-$58.53M
YoY Change	65.72%	67.11%
Common Stock	$74.85M	$74.13M
YoY Change	6.08%	6.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.207M	$2.318M
YoY Change
Treasury Stock Shares	$85.83K	$90.50K
Shareholders Equity	$7.081M	$13.27M	$13.27M
YoY Change
Total Liabilities & Shareholders Equity	$31.96M	$37.29M	$37.29M
YoY Change	-22.91%	3.68%	3.68%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	-$7.092M	-$7.232M	-$23.51M
YoY Change	55.11%	291.04%	-198.48%
Depreciation, Depletion And Amortization	$34.21K	$31.79K	$55.74K
YoY Change	615.47%
Cash From Operating Activities	-$5.255M	-$4.696M	-$13.95M
YoY Change	238.45%	137.32%	66.45%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$43.99K
YoY Change	-100.0%	-100.0%	20.42%
Acquisitions	$0.00		$11.64M
YoY Change	-100.0%
Other Investing Activities	$0.00	$0.00	-$15.35M
YoY Change	-100.0%	-100.0%	-156.04%
Cash From Investing Activities	$0.00	$0.00	-$15.39M
YoY Change	-100.0%	-100.0%	-156.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$30.43K	19.81M	$17.44M
YoY Change	-30.14%	80.94%	31.8%
NET CHANGE
Cash From Operating Activities	-$5.255M	-4.696M	-$13.95M
Cash From Investing Activities	$0.00	0.000	-$15.39M
Cash From Financing Activities	-$30.43K	19.81M	$17.44M
Net Change In Cash	-$5.285M	15.11M	-$11.89M
YoY Change	-35.8%	68.25%	-136.93%
FREE CASH FLOW
Cash From Operating Activities	-$5.255M	-$4.696M	-$13.95M
Capital Expenditures	$0.00	$0.00	$43.99K
Free Cash Flow	-$5.255M	-$4.696M	-$13.99M
YoY Change	238.45%	141.79%	66.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	69509606	usd
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2318182	usd
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	-0	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58534238	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35027588	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13274043	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	34548775	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37293985	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35970880	usd
CY2022	ctgo	Claim Rental Expense ClaimRentalExpense	621298	usd
CY2021	ctgo	Claim Rental Expense ClaimRentalExpense	210080	usd
CY2022	us-gaap	Exploration Expense ExplorationExpense	8517938	usd
CY2021	us-gaap	Exploration Expense ExplorationExpense	89817	usd
CY2022	us-gaap	Depreciation Nonproduction DepreciationNonproduction	55740	usd
CY2021	us-gaap	Depreciation Nonproduction DepreciationNonproduction	-0	usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6860420
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6769923
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6675746
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6675746
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	90497
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	0
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	35833175	usd
CY2022	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-0	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000
CY2021Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2020Q4	ctgo	Rights Agreement Number Of Preferred Stock Issuable Per Right RightsAgreementNumberOfPreferredStockIssuablePerRight	0.001
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	7.42	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	us-gaap	Accretion Expense AccretionExpense	9156	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	-0	usd
CY2022	ctgo	Impairment From Casualty Loss ImpairmentFromCasualtyLoss	92777	usd
CY2021	ctgo	Impairment From Casualty Loss ImpairmentFromCasualtyLoss	-0	usd
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-54136
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-3431051
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	3700 BUFFALO SPEEDWAY, SUITE 925
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77098
CY2022	dei	City Area Code CityAreaCode	713
CY2022	dei	Local Phone Number LocalPhoneNumber	877-1311
CY2022	dei	Security12g Title Security12gTitle	Common Stock, Par Value $0.01 per share
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Public Float EntityPublicFloat	91669837	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6775818
CY2022	dei	Auditor Name AuditorName	Moss Adams LLP
CY2022	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022	dei	Auditor Firm AuditorFirmId	659
CY2022	dei	Auditor Name AuditorName	Moss Adams LLP
CY2022	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23095101	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35220588	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	231000	usd
CY2021Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	453353	usd
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	515635	usd
CY2022Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	usd
CY2021Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	198126	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	23779454	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	35934349	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2021Q2	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13514531	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36531	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13514531	usd
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	36531	usd
CY2022Q2	us-gaap	Assets Assets	37293985	usd
CY2021Q2	us-gaap	Assets Assets	35970880	usd
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	66757	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74057859	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	633856	usd
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	26268	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	870981	usd
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	195837	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1504837	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	222105	usd
CY2022Q2	ctgo	Advance Royalty Reimbursement Noncurrent AdvanceRoyaltyReimbursementNoncurrent	1200000	usd
CY2021Q2	ctgo	Advance Royalty Reimbursement Noncurrent AdvanceRoyaltyReimbursementNoncurrent	1200000	usd
CY2022Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	228082	usd
CY2021Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	0	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1847063	usd
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	19239960	usd
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	22515105	usd
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1200000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	24019942	usd
CY2021Q2	us-gaap	Liabilities Liabilities	1422105	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	68604	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10336378	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10362281	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	19633287	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	10662178	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1503	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	1570	usd
CY2022	us-gaap	Interest Expense InterestExpense	330047	usd
CY2021	us-gaap	Interest Expense InterestExpense	-0	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3706000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3861252	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3706000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	41450	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2022	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	usd
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	39692857	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3993094	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23626381	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25170997	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-119731	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1301874	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-23506650	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	23869123	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.49
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.82
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.82
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6734444
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6250894
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6734444
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6253661
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-23506650	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	23869123	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3993660	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3892883	usd
CY2022	us-gaap	Depreciation Depreciation	55740	usd
CY2021	us-gaap	Depreciation Depreciation	0	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	9156	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	115025	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	34675	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3706000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3861252	usd
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	39692857	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-176914	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	443391	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1271899	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-867290	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-198126	usd
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	198126	usd
CY2022	ctgo	Increase Decrease In Advance Royalty Reimbursement IncreaseDecreaseInAdvanceRoyaltyReimbursement	0	usd
CY2021	ctgo	Increase Decrease In Advance Royalty Reimbursement IncreaseDecreaseInAdvanceRoyaltyReimbursement	1200000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13945455	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8378406	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3861252	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43989	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	36531	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	11642586	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	31250000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15392575	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27352217	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	779622	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	876551	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	19969967	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	164682	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2022	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	-43560	usd
CY2021	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	14111410	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17443543	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13234859	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11894487	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	32208670	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	35220588	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3011918	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23326101	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	35220588	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	218546	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1500000	usd
CY2022	ctgo	Stock Received And Retired From Sale Of Investment Value StockReceivedAndRetiredFromSaleOfInvestmentValue	0	usd
CY2021	ctgo	Stock Received And Retired From Sale Of Investment Value StockReceivedAndRetiredFromSaleOfInvestmentValue	8442857	usd
CY2022	ctgo	Asset Retirement Obligations Noncash Transaction AssetRetirementObligationsNoncashTransaction	218927	usd
CY2022	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	1847063	usd
CY2021	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	usd
CY2022	ctgo	Establishment Fee For Convertible Debt Paid With Stock Issuance EstablishmentFeeForConvertibleDebtPaidWithStockIssuance	600000	usd
CY2021	ctgo	Establishment Fee For Convertible Debt Paid With Stock Issuance EstablishmentFeeForConvertibleDebtPaidWithStockIssuance	0	usd
CY2022	ctgo	Fair Value Of Investing Activities Assumed FairValueOfInvestingActivitiesAssumed	2665990	usd
CY2021	ctgo	Fair Value Of Investing Activities Assumed FairValueOfInvestingActivitiesAssumed	8442857	usd
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	1994767	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3892883	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2021	ctgo	Stock Issued During Period Value New Issues And Treasury Stock Reissued StockIssuedDuringPeriodValueNewIssuesAndTreasuryStockReissued	14275004	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	163594	usd
CY2021	ctgo	Stock Received And Retired From Sale Of Investment Value StockReceivedAndRetiredFromSaleOfInvestmentValue	8442857	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	876551	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	23869123	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	34548775	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3993660	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022	ctgo	Stock Issued During Period Value New Issues And Treasury Stock Reissued StockIssuedDuringPeriodValueNewIssuesAndTreasuryStockReissued	600000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	43560	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	779622	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-23506650	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13274043	usd
CY2022	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b><em style="font: inherit;">2.</em> Basis of Presentation</b></p> <p style="margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. </p> <p style="margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </p>
CY2021	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	0	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	231000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<i>Management Estimates</i>. The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Other items subject to estimates and assumptions include, but are <em style="font: inherit;">not</em> limited to, the carrying amounts of property and equipment, asset retirement obligations, valuation of contingent consideration, valuation allowances for deferred income tax assets, valuation of derivative instruments and valuation of certain performance-based restricted stock unit awards. Management evaluates estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic and commodity price environment.
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-119731	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	92777	usd
	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	92777	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<i>Derivative Asset for Embedded Conversion Features.</i> The Company does <em style="font: inherit;">not</em> use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates convertible notes to determine if those contracts or embedded components of those contracts qualify as derivatives to be accounted for separately. In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are evaluated and accounted for separately. The result of this accounting treatment is that the fair value of the embedded derivative is recorded as either an asset or a liability and marked-to-market each balance sheet date, with the change in fair value recorded in the statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. The fair value of the embedded conversion features are estimated using several probability weighted binomial lattice models. The Company estimated the fair value of the convertible notes conversion feature at the time of issuance and subsequent remeasurement dates, utilizing the with-and without method, where the value of the derivative feature is the difference in values between a note simulated with the embedded conversion feature and the value of the same note simulated without the embedded conversion feature. Estimating fair values of embedded conversion features is classifed within Level <em style="font: inherit;">3</em> of the fair value hierarchy, and requires the development of significant and subjective estimates that <em style="font: inherit;"> may, </em>and are likely to, change over the duration of the instrument with related changes in internal and external market factors.
CY2022	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	9156	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	453353	usd
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	515635	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation Restricted Stock Shortfall Amount EffectiveIncomeTaxRateReconciliationRestrictedStockShortfallAmount	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-23506650	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	23869123	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6734444
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6250894
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2767
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6734444
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6253661
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.49
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.82
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.82
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6769923
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	ctgo	Rights Agreement Exercise Price RightsAgreementExercisePrice	100.00
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	55740	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	115025	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13514531	usd
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36531	usd
CY2021	ctgo	Effective Income Tax Rate Reconciliation Restricted Stock Shortfall Amount EffectiveIncomeTaxRateReconciliationRestrictedStockShortfallAmount	162750	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation Legal Fees Amount EffectiveIncomeTaxRateReconciliationLegalFeesAmount	131311	usd
CY2021	ctgo	Effective Income Tax Rate Reconciliation Legal Fees Amount EffectiveIncomeTaxRateReconciliationLegalFeesAmount	0	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation Convertible Debt Interest Amount EffectiveIncomeTaxRateReconciliationConvertibleDebtInterestAmount	66463	usd
CY2021	ctgo	Effective Income Tax Rate Reconciliation Convertible Debt Interest Amount EffectiveIncomeTaxRateReconciliationConvertibleDebtInterestAmount	0	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation162m Limitation Amount EffectiveIncomeTaxRateReconciliation162mLimitationAmount	84822	usd
CY2021	ctgo	Effective Income Tax Rate Reconciliation162m Limitation Amount EffectiveIncomeTaxRateReconciliation162mLimitationAmount	0	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5990215	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-6966500	usd
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3993660	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3892883	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	7.42	usd
CY2019Q1	ctgo	Contingent Salary And Compensation Retention Agreement ContingentSalaryAndCompensationRetentionAgreement	1500000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4961540	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	5285909	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1544567	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2829625	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	-38	usd
CY2021	ctgo	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	-161474	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation Permanent Differences Amount EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount	12937	usd
CY2021	ctgo	Effective Income Tax Rate Reconciliation Permanent Differences Amount EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount	472	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation Transaction Costs Amount EffectiveIncomeTaxRateReconciliationTransactionCostsAmount	0	usd
CY2021	ctgo	Effective Income Tax Rate Reconciliation Transaction Costs Amount EffectiveIncomeTaxRateReconciliationTransactionCostsAmount	73182	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	100666	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	77910	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1301874	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-261636	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	915234	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	141905	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	386640	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-119731	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1301874	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022Q2	ctgo	Deferred Tax Assets Capitalized Exploration DeferredTaxAssetsCapitalizedExploration	8278223	usd
CY2021Q2	ctgo	Deferred Tax Assets Capitalized Exploration DeferredTaxAssetsCapitalizedExploration	6016386	usd
CY2022Q2	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	3503066	usd
CY2021Q2	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	1846393	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1425498	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1900850	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2547058	usd
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	0	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15753845	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9763629	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6000000.0	usd

Files In Submission

Name	View Source	Status
0001437749-22-021579-index-headers.html	Edgar Link	pending
0001437749-22-021579-index.html	Edgar Link	pending
0001437749-22-021579.txt	Edgar Link	pending
0001437749-22-021579-xbrl.zip	Edgar Link	pending
cdsoil.jpg	Edgar Link	pending
conta20220630b_10k.htm	Edgar Link	pending
ctgo-20220630.xsd	Edgar Link	pending
ex_414301.htm	Edgar Link	pending
ex_414302.htm	Edgar Link	pending
ex_414303.htm	Edgar Link	pending
ex_414304.htm	Edgar Link	pending
ex_414305.htm	Edgar Link	pending
ex_414306.htm	Edgar Link	pending
ex_414307.htm	Edgar Link	pending
ex_414308.htm	Edgar Link	pending
ex_414310.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
in-filldrillholesmap.jpg	Edgar Link	pending
mainandnorthmanhchohdeposits.jpg	Edgar Link	pending
malogo.jpg	Edgar Link	pending
manhchohdrillingprogram2021-.jpg	Edgar Link	pending
mapofhonaholes2019program-up.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
programeastpeakandnorths.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
ctgo-20220630_cal.xml	Edgar Link	unprocessable
ctgo-20220630_def.xml	Edgar Link	unprocessable
ctgo-20220630_pre.xml	Edgar Link	unprocessable
ctgo-20220630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
conta20220630b_10k_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shamrockprospectmap2021.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
willow.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTGO
Contango ORE, Inc. Stock $ctgo

2022 Q3 Form 10-K Financial Statement

#000143774922021579 Filed on August 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTGO Contango ORE, Inc. Stock $ctgo

2022 Q3 Form 10-K Financial Statement

#000143774922021579 Filed on August 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTGO
Contango ORE, Inc. Stock $ctgo